Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Rheumatology

Does IMNM Cause Severe Muscle Pain? Evaluation and Care

At a Glance

Immune-mediated necrotizing myopathy can cause significant or severe muscle pain, although progressive weakness is more typical. Pain alone cannot show whether the disease is active, so doctors also assess strength, muscle enzyme levels, and sometimes imaging or electrical muscle testing.

While immune-mediated necrotizing myopathy (IMNM) is classically defined by progressive muscle weakness, it can also cause significant muscle pain (myalgia). Although the medical term “necrotizing” refers to muscle-fiber injury or death and is sometimes assumed to be a painless process, research confirms that muscle pain is a recognized—though variable—symptom of IMNM, which can sometimes be severe [1].

It is important to understand that pain by itself does not prove the disease is active or flaring. However, if you are experiencing severe or new muscle pain, you should report it to your rheumatologist so they can properly evaluate your symptoms in combination with other tests [2].

When to Seek Urgent Care

Severe muscle pain can sometimes be a sign of a medical emergency. Seek urgent medical assessment if you experience:

  • Dark or “cola-colored” urine, or a marked decrease in urination (signs of a serious condition called rhabdomyolysis)
  • Rapidly progressing weakness, such as suddenly being unable to stand or use a limb
  • New difficulty swallowing or breathing
  • High fever or severe systemic illness

Pain Frequency by IMNM Subtype

The likelihood of experiencing muscle pain with IMNM can vary depending on your specific disease subtype. The following statistics come from specific observational studies and represent estimates from those groups of patients, rather than a strict rule for everyone:

  • Seronegative IMNM: This refers to patients whose blood tests do not detect the currently recognized IMNM antibodies (anti-SRP or anti-HMGCR). In one study of 117 IMNM patients, 62.5% of those in the seronegative group reported muscle pain when their symptoms first appeared, compared to 23.3% of the antibody-positive group [1].
  • Anti-SRP IMNM: Muscle pain is a frequent feature in this subtype. One study tracking patients with anti-SRP antibodies found that 54% experienced myalgia [3].
  • Anti-HMGCR IMNM: Symptoms in this group can be highly variable. Some patients experience significant pain alongside weakness and elevated muscle enzymes [2]. Conversely, other patients may only experience painless, progressive weakness despite having active muscle injury and high enzyme levels [4].

Evaluating Muscle Pain

Severe muscle pain should not be ignored, as it can occur alongside objective evidence of active muscle injury and degeneration [2]. During an active disease phase, your pain may be accompanied by increasing weakness, abnormalities on a muscle MRI (magnetic resonance imaging), and elevated levels of creatine kinase (CK), an enzyme that leaks into the blood when muscle fibers are damaged [2].

However, because pain intensity alone cannot confirm disease activity or rule out other causes, your care team will look at the full picture. Muscle pain can also result from unrelated issues, such as:

  • Viral infections [5]
  • Radiculopathy (pain caused by an irritated or pinched nerve) [6]
  • Side effects from other medications, particularly statins or certain other drugs

To determine the cause of your pain, your doctor will likely evaluate your symptoms in combination with your CK trends, physical strength, and potentially an MRI or EMG (electromyography, a test of electrical nerve and muscle function). Always review all of your current medications with your clinician, and do not stop taking any prescribed treatments—including immunosuppressants or statins—without their guidance.

Common questions in this guide

Is severe muscle pain a symptom of immune-mediated necrotizing myopathy?
Yes. IMNM can cause significant or severe muscle pain, although progressive muscle weakness is more characteristic and pain varies by person and subtype. Pain alone does not prove that the disease is active.
Does severe pain mean that my IMNM is active?
Not necessarily. Pain can accompany active muscle injury, but pain intensity alone cannot confirm a flare. Clinicians usually consider changes in strength, creatine kinase blood tests, and sometimes MRI or EMG while also looking for other causes.
What tests can help find the cause of pain in IMNM?
A clinician may check creatine kinase levels, examine muscle strength, and consider an MRI or EMG. They may also review medications and ask about viral illness or pinched nerves because these can cause muscle pain for other reasons.
When should I seek urgent care for muscle pain with IMNM?
Get urgent medical assessment for dark or cola-colored urine, a marked decrease in urination, rapidly worsening weakness, new trouble swallowing or breathing, or high fever and severe illness. These symptoms can signal rhabdomyolysis or another serious problem.
Does muscle pain occur equally in every IMNM subtype?
No. Studies report different rates of muscle pain in seronegative and antibody-positive IMNM, and anti-HMGCR disease can range from painful weakness to painless progressive weakness. Study estimates cannot predict exactly how symptoms will affect one individual.
Should I stop a statin or immunosuppressant if I develop muscle pain?
Do not stop a prescribed statin, immunosuppressant, or other treatment without speaking with your clinician. Review all current medications with the care team because medication side effects can sometimes contribute to muscle pain.

Get notified when new evidence is published on Immune-mediated necrotizing myopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Necrotizing Myopathy in China.

    Ma X, Xu L, Ji S, et al.

    Frontiers in neurology 2021; (12()):670784 doi:10.3389/fneur.2021.670784.

    PMID: 34290662
  2. 2

    [Anti-HMGCR immune-mediated necrotizing myopathy: A case report].

    Zhang YJ, Ma JY, Liu XY, et al.

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2023; (55(3)):558-562.

    PMID: 37291935
  3. 3

    Profiling of Anti-Signal-Recognition Particle Antibodies and Clinical Characteristics in South Korean Patients With Immune-Mediated Necrotizing Myopathy.

    Kim SH, Choi Y, Oh EK, et al.

    Journal of clinical neurology (Seoul, Korea) 2025; (21(1)):31-39 doi:10.3988/jcn.2024.0333.

    PMID: 39778565
  4. 4

    Statin-Associated Necrotizing Autoimmune Myopathy: Unmasking 3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR) Antibody-Positive Disease After Statin Re-exposure.

    Cafuli A, Martins A, Ohonba N, et al.

    Cureus 2025; (17(8)):e89275 doi:10.7759/cureus.89275.

    PMID: 40909054
  5. 5

    Steroid-Responsive Seronegative Immune-Mediated Necrotizing Myopathy Likely Triggered by Coxsackie B Virus: A Case Report.

    Kumar M, Ali SM, Kumar V, et al.

    Cureus 2024; (16(6)):e63394 doi:10.7759/cureus.63394.

    PMID: 39070481
  6. 6

    When Statins Get Physical: A Curious Cause of Statin Myopathy.

    Patel PP, Jackson CD

    Southern medical journal 2022; (115(4)):266-269 doi:10.14423/SMJ.0000000000001379.

    PMID: 35365843

This page is for informational purposes only and does not constitute medical advice. A rheumatologist should evaluate new or severe pain, and dark urine, rapidly worsening weakness, or breathing or swallowing problems require urgent medical care.